We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+5.65%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.01B
AUM Growth
+$205M
(+25%)
Cap. Flow
+$234M
Cap. Flow
% of AUM
23.15%
Top 10 Holdings %
Top 10 Hldgs %
4.25%
Holding
2,085
New
689
Increased
399
Reduced
339
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
National Vision
EYE
|
+$5.45M |
| 2 |
Altimmune
ALT
|
+$4.45M |
| 3 |
FRC
First Republic Bank
FRC
|
+$4.06M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.99M |
| 5 |
Hilton Worldwide
HLT
|
+$3.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$7.74M |
| 2 |
Dropbox
DBX
|
+$3.02M |
| 3 |
Progressive
PGR
|
+$2.77M |
| 4 |
Southwest Airlines
LUV
|
+$2.69M |
| 5 |
Transocean
RIG
|
+$2.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 14.87% |
| 3 | Healthcare | 14.13% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Liberty Latin America Class A
LILA
$1.67B
| $497K | 0.05% |
+87,973
| New | +$523K |
|
727
Universal Electronics
UEIC
$61.3M
| $497K | 0.05% |
+48,982
| New | +$853K |
|
728
Monro
MNRO
$398M
| $495K | 0.05% |
10,024
-21,752
| -68% | -$1.08M |
|
|
ASXC
729
DELISTED
Asensus Surgical, Inc.
ASXC
| $493K | 0.05% |
749,800
-218,236
| -23% | -$148K |
|
730
Consensus Cloud Solutions
CCSI
$647M
| $491K | 0.05% |
+14,392
| New | +$693K |
|
731
Keurig Dr Pepper
KDP
$40.8B
| $490K | 0.05% |
13,892
-14,747
| -51% | -$518K |
|
|
NEUE
732
DELISTED
NeueHealth
NEUE
| $489K | 0.05% |
27,730
+27,117
| +4,424% | +$1.4M |
|
733
Booking.com
BKNG
$161B
| $488K | 0.05% |
+4,600
| New | +$448K |
|
|
DAWN
734
DELISTED
Day One Biopharmaceuticals
DAWN
| $488K | 0.05% |
+36,494
| New | +$713K |
|
735
Enviri
NVRI
$620M
| $488K | 0.05% |
71,401
+61,072
| +591% | +$460K |
|
|
NATI
736
DELISTED
National Instruments Corp
NATI
| $488K | 0.05% |
9,306
+1,341
| +17% | +$67.3K |
|
|
NVRO
737
DELISTED
NEVRO CORP.
NVRO
| $487K | 0.05% |
13,477
-19,326
| -59% | -$679K |
|
|
NVTA
738
DELISTED
Invitae Corporation
NVTA
| $487K | 0.05% |
360,621
+333,081
| +1,209% | +$656K |
|
739
CNX Resources
CNX
$5.2B
| $484K | 0.05% |
+30,189
| New | +$480K |
|
740
Emcor
EME
$36B
| $484K | 0.05% |
2,974
-2,346
| -44% | -$361K |
|
741
Hims & Hers Health
HIMS
$7.31B
| $482K | 0.05% |
48,606
-224,925
| -82% | -$1.97M |
|
742
WesBanco
WSBC
$4B
| $482K | 0.05% |
15,690
-2,232
| -12% | -$78.9K |
|
743
Atea Pharmaceuticals
AVIR
$420M
| $480K | 0.05% |
143,170
+86,250
| +152% | +$350K |
|
744
Jackson Financial
JXN
$8.8B
| $475K | 0.05% |
12,688
-3,567
| -22% | -$146K |
|
745
Merchants Bancorp
MBIN
$2.49B
| $475K | 0.05% |
+18,225
| New | +$505K |
|
746
PDF Solutions
PDFS
$2.07B
| $475K | 0.05% |
+11,199
| New | +$392K |
|
747
Veritone
VERI
$122M
| $474K | 0.05% |
81,376
+9,560
| +13% | +$65.8K |
|
748
Crinetics Pharmaceuticals
CRNX
$8.92B
| $473K | 0.05% |
+29,455
| New | +$545K |
|
749
Kopin
KOPN
$791M
| $473K | 0.05% |
433,669
-55,841
| -11% | -$68.3K |
|
750
Essential Utilities
WTRG
$11.4B
| $473K | 0.05% |
+10,830
| New | +$489K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2023 Portfolio in Review
As of Q1 2023, GSA Capital Partners held 2,085 positions worth $1.01B, up 25% from $806M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
GSA Capital Partners deployed $234M of net new capital in Q1 2023, opening 689 new positions and adding to 399 existing holdings. Its largest new stake was National Vision: 167,499 shares worth $3.16M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Transocean, an estimated $2.59M trimmed.
- GSA Capital Partners's largest Q1 2023 buy was National Vision: 167,499 shares worth $3.16M.
- GSA Capital Partners added most to Altimmune in Q1 2023, an estimated $4.45M increase.
- GSA Capital Partners's biggest Q1 2023 reduction was Transocean, cutting an estimated $2.59M.
- GSA Capital Partners fully exited PG&E in Q1 2023, selling an estimated $7.74M.
- GSA Capital Partners's ten largest holdings make up 4.2% of its $1.01B portfolio in Q1 2023.
- GSA Capital Partners opened 689 new positions and closed 654 in Q1 2023.
- GSA Capital Partners's portfolio value rose 25% quarter-over-quarter to $1.01B.
Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.